HUMA KHALIL: Open Payments
NPI 1831175892 · RESTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$224 in 8 payments from 5 companies in 2025. Trend: 2023 $179 · 2024 $118 · 2025 $224
Food & beverage: $149Education: $76
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $107 |
| Alkermes, Inc. | 2 | $37 |
| Neurocrine BioSciences, Inc. | 2 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: ARISTADA, UZEDY, INGREZZA, COBENFY, ABILIFY ASIMTUFII.
Industry payments across VA — which companies pay providers there.
